Na-131I (solution for injection)

MI-2

Indications

The medicinal product is used:

  • in the diagnosis of thyroid function disorders (hyperthyroidism and hypothyroidism), evaluation of thyroid tissue location (including ectopy), its size, shape, functional analysis of focal lesions: “cold” (not trapping iodine), “warm” (trapping iodine at a similar extent to normal thyroid parenchyma), “hot” (trapping iodine at a higher extent than the normal thyroid parenchyma) nodules.
  • to study radioiodine location in thyroid tissue
  • an estimation of the thyroid uptake and the iodine effective half-life can be used to calculate the dose of radioiodine planned for therapy.
  • in the management of patients with differentiated thyroid carcinoma in order to identify the remaining thyroid tissue after surgery and in the diagnostics of metastases.
  • in the treatment of benign thyroid diseases: thyroid nodular goitre, hyperthyroidism in the Graves-Basedow’s disease, autonomic nodule, the toxic multinodular goiter, differentiated thyroid cancer, for the thyroid residue ablation after surgery and in the treatment of iodine-accumulating metastases.

Labelling activity
?

Shelf life
28 days from the production date

Shelf-life and storage conditions after radiolabelling

  • at temperature below 25ºC

Radioisotope Centre POLATOM works for over 60 years as a major Polish supplier of radiopharmaceuticals, sealed and standard radiation sources, radionuclide generators, radiochemical reagents, and custom radioactive preparations for medicine, research, industry and environmental monitoring.

POLATOM operates under the umbrella of National Centre for Nuclear Research (NCBJ) and delivers products — including diagnostic kits using 99mTc, iodine-131 therapies, sealed gamma sources, and calibration standards — to thousands of customers across dozens of countries worldwide.